home / stock / acer / acer news

ACER News and Press, Acer Therapeutics Inc. From 10/07/21

Stock Information
Company Name: Acer Therapeutics Inc.
Stock Symbol: ACER
Market: NASDAQ
Website: acertx.com
Menu
ACER ACER Quote ACER Short ACER News ACER Articles ACER Message Board
Get ACER Alerts

News, Short Squeeze, Breakout and More Instantly...
ACER - JYNT, BCYC and FAMI among mid-day movers

Gainers: Camber Energy (NYSE:CEI) +97%. Merus (NASDAQ:MRUS) +32%. New Fortress Energy (NASDAQ:NFE) +25%. Paltalk (NASDAQ:PALT) +25%. Grom Social Enterprises (NASDAQ:GROM) +20%. DatChat (NASDAQ:DATS) +20%. Jupiter Wellness (NASDAQ:JUPW) +18%. NextPlay Technologies (NASDAQ:NXTP) +19%. Independe...
ACER - Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation

NEWTON, Mass. and GENEVA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Patent and Trademark Office...

ACER - "The Buzz" Show: Acer Therapeutics Inc. (NASDAQ: ACER) FDA Acceptance for ACER-001

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Acer Therapeutics Inc. and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001” Acer Therapeutics Inc. (NASDAQ: ACER) c...

ACER - AFRM, UUUU and ANY among mid-day movers

Gainers: Voyager (NASDAQ:VYGR) +44%. Grom Social Enterprises (NASDAQ:GROM) +26%. Bit Digital (NASDAQ:BTBT) +16%. Resonant (NASDAQ:RESN) +16%. Affirm Holdings (NASDAQ:AFRM) +14%. Acer (NASDAQ:ACER) +12%. Acuity Brands (NYSE:AYI) +12%. SGOCO Group (NASDAQ:SGOC) +14%. Xenon Pharmaceuticals (NASD...
ACER - Voyager Therapeutics, Molecular Partners leads healthcare gainers; Ginkgo Bioworks, OpGen among major losers

Gainers: Voyager Therapeutics (NASDAQ:VYGR) +57%, Acer Therapeutics (NASDAQ:ACER) +9%, Molecular Partners (NASDAQ:MOLN) +10%, Rafael (NYSE:RFL) +6%, Arcturus Therapeutics (NASDAQ:ARCT) +7%. Losers: Ginkgo Bioworks (NYSE:DNA) -21%, OpGen (...

ACER - Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders

NEWTON, Mass. and GENEVA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Food and Drug Administratio...

ACER - ACER, TOMZ and IPDN among pre market gainers

Voyager Therapeutics (NASDAQ:VYGR) +44% Pfizer in pact with Voyager Therapeutics to develop gene therapies Acer Therapeutics (NASDAQ:ACER) +14%. Kaixin Auto (NASDAQ:KXIN) +8% as POCCO EV orders surpassed 3000 units in September, +130% M/M Palantir Technologies (NYSE:PLTR)&...
ACER - Acer Therapeutics: Deriving Value By Developing Therapies For Rare Diseases

Acer Therapeutics is a pharmaceutical company that acquires, develops and seeks to commercialize therapies for serious, rare, and life-threatening diseases. Acer submitted an NDA for its lead drug candidate ACER-001 for treatment of UCDs in early August. Acer expects notification ...

ACER - Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

NEWTON, Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced th...

ACER - Acer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update

NEWTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported fin...
Previous 10 Next 10